Evaluation of immune response and protection in animals given mink parvovirus vaccines

Biologicals

Volumn 25, Issue 1, 1997, Pages 93-101

  Zhang, De Li ^a,d,e   Yindagger, Zhen ^b   Wang, Shu Zi ^c  

^a Chinese Army Lab of Molec V   (China)

^b CHANGCHUN UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

^d Qiaoguang Inst of Med / Hlth S ^*  (China)

^e Qiaoguang Inst of Med / Hlth S   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; HEMAGGLUTINATION INHIBITING ANTIBODY; MINERAL OIL; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG MONITORING; DRUG POTENCY; DRUG STABILITY; GUINEA PIG; HUMORAL IMMUNITY; IMMUNE RESPONSE; MINK; MONITORING; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROVOCATION TEST; RABBIT;

ANIMALIA; CAVIA; CAVIA PORCELLUS; MINK ENTERITIS VIRUS; MUSTELA VISON; ORYCTOLAGUS CUNICULUS; PARVOVIRUS; SUS SCROFA;

EID: 0031105158     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1996.0064     Document Type: Article

References (30)

1. 1. Parrish C, Carmichael L, Antczak D. Antigenic relationship between canine parvovirus type 2, feline panleukopenia virus and mink enteritis virus using conventional antisera and monoclonal antibodies. Arch Virol 1982; 72: 267-278.
2. 2. Tratschin JD, McMaster GK, Kronauer G, Siegel G. Canine parvovirus: relationship to wild-type and vaccine strains of feline panleukopenia virus and mink enteritis virus. J Gen Virol 1982; 61: 33-41.
3. 3. Barker IK, Povey RC, Voigt DR. Response of mink, skunk, red fox and raccoon to inoculation with mink enteritis, feline panleukopenia and canine parvovirus and prevalence of antibody to parvovirus in wild carnivores in Ontario. Can J Comp Med 1983; 47: 188-197.
4. 4. Carman PS, Povey RC. Comparison on viral proteins among canine parvovirus type-2, mink enteritis virus and feline panleukopenia virus. Vet Microbiol 1983; 8: 423-435.
5. 5. Goto H et al. Comparison on biological and physical characteristics among mink enteritis virus, feline panleukopenia virus and canine parvovirus. Jpn J Vet Sci 1986; 48: 1025-1028.
6. 6. Parrish CR, Leather CW, Pearson R, Gorham JR. Comparison of feline panleukopenia virus, canine parvovirus, raccoon parvovirus & mink enteritis virus & their pathogenicity for mink and ferrets. Am J Vet Res 1987; 48: 1429-1435.
7. 7. McMaster GK, Tratschin JD, Siegel G. Comparison of canine parvovirus with mink enteritis virus by restriction site mapping. J Virol 1981; 38: 368-371.
8. 8. Rivera E, Sundquits B. A non-haemagglutination isolate of mink enteritis virus. Vet Microbiol 1984; 9: 345-353.
9. 9. Pollock R, Carmichael L. Use of modified live feline panleukopenia virus vaccine to immunize dogs against canine parvovirus. Am J Vet Res 1983; 44: 168-175.
10. 10. Goto H et al. Comparative studies of physicochemical and biological properties between canine parvovirus and feline panleukopenia virus. Jpn J Vet Sci 1984; 46: 519-529.
11. 11. Fields BN et al. Virology, 1st edition. Raven Press, New York, 1985; pp. 411-432.
12. 12. Joo HS, Molitor TW, Leman AD. Antibody responses of guinea pigs, rabbits and pigs to inactivated porcine parvovirus vaccines. Vet Microbiol 1984; 9: 27-33.
13. 13. Cole Jr. FE, McKinney RW. Use of hamsters for potency assay of Eastern and Western equine encephalitis vaccines. Appl Microbiol 1969; 17: 927-928.
14. 14. Koprowski H. Guinea pig potency test for chicken embryo vaccine. In: Laboratory Techniques in Rabies; 3rd edn., WHO, Rome, 1973, pp. 287-291.
15. 15. Zhang, DL et al. Development of mink parvovirus vaccines. Biologicals 1997; 25: 103-111.
16. 3 gel adjuvant from serum-free cell cultures of mink enteritis virus (MEV). A Letter. Chinese Science Bulletin 1990; 35: 174-176.
17. 17. Fastier LB. Feline panleukopenia - a serological study. Vet Res 1968; 83: 653-655.
18. 18. Chapek ML, McClaughry LE, Wilkins LM. Efficacy and safety of an inactivated feline parvovirus vaccine against canine parvovirus infection. Mod Vet Pract 1980; 61: 261-263.
19. 19. Bittle JL, Emrich SA, Gauker FB. Safety and efficacy of an inactivated tissue culture vaccine for feline panleukopenia. JAVMA 1970; 157: 2052-2056.
20. 20. Carmichael L, Joubert J, Pollock R. Haemagglutination by canine parvovirus: serological studies and diagnostic application. Am J Vet Res 1980; 41: 784-791.
21. 21. Eugster AK. Studies on canine parvovirus infection: development of an inactivated vaccine. Am J Vet Res 1980; 41: 2020-2024.
22. 22. Higashihara T, Izawa H, Onuma M, Kodama H, Mikami T, Noda H. Mink enteritis in Japan I. Isolation and characterization of the causative virus and its pathogenicity in cat. Jpn J Vet Sci 1981; 43: 841-851.
23. 23. Wierup M, Olsson P, Hedhammar A, Klingeborn B, Karlisson KA. Evaluation of a killed feline panleukopenia virus vaccine against canine parvovirus enteritis in dogs. Am J Vet Res 1982; 43: 2183-2187.
24. 2 of canine parvovirus as a synthetic peptide. Vaccine 1994; 12: 1473-1480.
25. 25. Parrish CR, Aquadro CF, Carmichael LE. Canine host range and a specific epitope map along with variant sequences in the capsid protein gene of canine parvovirus and related feline, mink and raccoon parvoviruses. Virology 1988; 166: 293-307.
26. 26. Parrish CR. Emergence, natural history and variation of canine, mink and feline parvovirus. Adv Virus Res 1990; 38: 403-450.
27. 27. Martyn JC, Davidson BE, Studdart MJ. Nucleotide sequence of feline panleukopenia virus: comparison with canine parvovirus identifies host-specific differences. J Gen Virol 1990; 71: 2747-2753.
28. 28. Parrish CR. The emergence and evolution of canine parvovirus - an example of recent host range mutation. Seminars in Virology 1994; 5: 121-132.
29. 29. Veijalainen P. Characterization of biological and antigenic properties of raccoon dog and blue fox parvoviruses: a monoclonal antibody study. Vet Microbiol 1988; 16: 219-230.
30. 30. Parrish CR. Mapping specific funtions in the capsid structure of canine parvovirus and feline panleukopenia virus using infectious plasmid clones. Virology 1991; 183: 195-205.